122 related articles for article (PubMed ID: 1502887)
1. Radio-immunotargeting in experimental animal models of intraperitoneal cancer.
Fjeld JG; Vergote I; De Vos L; Nustad K
Acta Obstet Gynecol Scand Suppl; 1992; 155():105-11. PubMed ID: 1502887
[TBL] [Abstract][Full Text] [Related]
2. Improved intratumoral penetration of radiolabeled streptavidin in intraperitoneal tumors pretargeted with biotinylated antibody.
Zhang M; Yao Z; Saga T; Sakahara H; Nakamoto Y; Sato N; Nakada H; Yamashina I; Konishi J
J Nucl Med; 1998 Jan; 39(1):30-3. PubMed ID: 9443734
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.
Andersson H; Lindegren S; Back T; Jacobsson L; Leser G; Horvath G
Anticancer Res; 2000; 20(1A):459-62. PubMed ID: 10769696
[TBL] [Abstract][Full Text] [Related]
4. Potential and limitations of radioimmunodetection and radioimmunotherapy with monoclonal antibodies.
Zhu H; Baxter LT; Jain RK
J Nucl Med; 1997 May; 38(5):731-41. PubMed ID: 9170438
[TBL] [Abstract][Full Text] [Related]
5. Quantitative immuno-SPECT monitoring of pretargeted radioimmunotherapy with a bispecific antibody in an intraperitoneal nude mouse model of human colon cancer.
Schoffelen R; van der Graaf WT; Sharkey RM; Franssen GM; McBride WJ; Chang CH; Bos DL; Goldenberg DM; Oyen WJ; Boerman OC
J Nucl Med; 2012 Dec; 53(12):1926-32. PubMed ID: 23081995
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal indium-111- and yttrium-90-labeled human IgM (AC6C3-2B12) in nude mice bearing peritoneal carcinomatosis.
Quadri SM; Malik AB; Chu HB; Freedman RS; Vriesendorp HM
J Nucl Med; 1996 Sep; 37(9):1545-51. PubMed ID: 8790216
[TBL] [Abstract][Full Text] [Related]
7. Improved radiolabeled monoclonal antibody uptake by lavage of intraperitoneal carcinomatosis in mice.
Wahl RL; Liebert M
J Nucl Med; 1989 Jan; 30(1):60-5. PubMed ID: 2911043
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
[TBL] [Abstract][Full Text] [Related]
9. Avidin-biotin system pretargeting radioimmunoimaging and radioimmunotherapy and its application in mouse model of human colon carcinoma.
Li GP; Zhang H; Zhu CM; Zhang J; Jiang XF
World J Gastroenterol; 2005 Oct; 11(40):6288-94. PubMed ID: 16419157
[TBL] [Abstract][Full Text] [Related]
10. Immunoconjugate stability in vivo measured by label release from 125I or 99mTc-antibody coated cells kept in intraperitoneal diffusion chambers in mice.
Fjeld J; Brorson B; Martinussen GK; Benestad H; Nustad K
Acta Oncol; 1993; 32(7-8):873-6. PubMed ID: 8305239
[TBL] [Abstract][Full Text] [Related]
11. Growth of rat-mouse hybridomas in nude mice and nude rats.
Noeman SA; Misra DN; Yankes RJ; Kunz HW; Gill TJ
J Immunol Methods; 1982 Dec; 55(3):319-26. PubMed ID: 6762397
[TBL] [Abstract][Full Text] [Related]
12. [The study of radioimmunoimaging on the nude mice bearing human ovarian carcinoma by labelling monoclonal antibody with 99mTc].
Lin W; Qian H; Feng J
Zhonghua Fu Chan Ke Za Zhi; 1996 May; 31(5):308-10. PubMed ID: 9206189
[TBL] [Abstract][Full Text] [Related]
13. CaNa2EDTA for improvement of radioimmunodetection and radioimmunotherapy with 111In and 90Y-DTPA-anti-CEA MAbs in nude mice bearing human colorectal cancer.
Watanabe N; Oriuchi N; Endo K; Inoue T; Kuroki M; Matsuoka Y; Tanada S; Murata H; Kim EE; Sasaki Y
J Nucl Med; 2000 Feb; 41(2):337-44. PubMed ID: 10688120
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunoscintigraphy and radioimmunotherapy in nude mouse models. Studies with site-specifically modified monoclonal antibodies.
Alvarez VL; Lopes AD; Rodwell JD; McKearn TJ; Stuart FP
Targeted Diagn Ther; 1989; 2():99-118. PubMed ID: 2519552
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis.
Koppe MJ; Hendriks T; Boerman OC; Oyen WJ; Bleichrodt RP
J Nucl Med; 2006 Nov; 47(11):1867-74. PubMed ID: 17079821
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunotargeting of human tumour cells in immunocompetent animals.
Fjeld JG; Bruland OS; Benestad HB; Schjerven L; Stigbrand T; Nustad K
Br J Cancer; 1990 Oct; 62(4):573-8. PubMed ID: 2223574
[TBL] [Abstract][Full Text] [Related]
17. Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody.
Chrastina A; Pastoreková S; Pastorek J
Neoplasma; 2003; 50(1):13-21. PubMed ID: 12687273
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal radioimmunotherapy with human monoclonal IGM in nude mice with peritoneal carcinomatosis.
Borchardt PE; Quadri SM; Freedman RS; Vriesendorp HM
Cancer Biother Radiopharm; 2000 Feb; 15(1):53-64. PubMed ID: 10740653
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
[TBL] [Abstract][Full Text] [Related]
20. Preclinical analysis of intraperitoneal administration of 111In-labeled human tumor reactive monoclonal IgM AC6C3-2B12.
Quadri SM; Malik AB; Tang XZ; Patenia R; Freedman RS; Vriesendorp HM
Cancer Res; 1995 Dec; 55(23 Suppl):5736s-5742s. PubMed ID: 7493338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
